<p>Upper: Photomicrographs of DA D<sub>2</sub> receptor expression in the hypothalamus. WB: Whole brain. The sections were stained for DA D<sub>2</sub> receptor immunoreactivity (brown). The scale bars represent 50 µm (WB) and 200 µm (A–E). Lower: DA D<sub>2</sub> receptor expression in each group *<i>p</i><0.05 compared to the control group. <sup>†</sup><i>p</i><0.05 compared to the untreated ADHD group. <sup>‡</sup><i>p</i><0.05 compared to the untreated ADHD and 0.25 mg/kg/d atomoxetine-treated ADHD groups. The data have been presented as mean ±SEM.</p
The stimulant methylphenidate and the non-stimulant atomoxetine are widely used for the treatment of...
Objective: The effects of a promising pharmacological treatment for attention-deficit/hyperactivity ...
Attention-deficit/hyperactivity disorder (ADHD) is a complex neurobehavioral disorder that is charac...
<p>Upper: Photomicrographs of DA D<sub>2</sub> receptor expression in the pre-frontal cortex. WB: Wh...
<p>Upper: Photomicrographs of DA D<sub>2</sub> receptor expression in the striatum. WB: Whole brain....
Hyperactivity related behaviors as well as inattention and impulsivity are regarded as the nuclear s...
Background: Hyperactivity related behaviors as well as inattention and impulsivity are regarded as t...
The selective norepinephrine (NE) transporter inhibitor atomoxetine (formerly called tomoxetine or L...
Methylphenidate and atomoxetine are effective in treating attention-deficit/hyperactivity disorder (...
Background. Methylphenidate and atomoxetine are commonly prescribed for treating attention deficit h...
4. Pharmacol Res. 2010 Dec;62(6):523-9. Epub 2010 Aug 5. Sub-chronic exposure to atomoxetine up-r...
Objective: The effects of a promising pharmacological treatment for attention-deficit/hyperactivity ...
Background: Atomoxetine, a selective noradrenaline reuptake inhibitor (SNRI) licensed for the treatm...
Copyright © 2013 Ramiz M. Salimov, Georgy I. Kovalev. This is an open access article distributed und...
RATIONALE: Attention-deficit hyperactivity disorder (ADHD) is the most frequently diagnosed neur...
The stimulant methylphenidate and the non-stimulant atomoxetine are widely used for the treatment of...
Objective: The effects of a promising pharmacological treatment for attention-deficit/hyperactivity ...
Attention-deficit/hyperactivity disorder (ADHD) is a complex neurobehavioral disorder that is charac...
<p>Upper: Photomicrographs of DA D<sub>2</sub> receptor expression in the pre-frontal cortex. WB: Wh...
<p>Upper: Photomicrographs of DA D<sub>2</sub> receptor expression in the striatum. WB: Whole brain....
Hyperactivity related behaviors as well as inattention and impulsivity are regarded as the nuclear s...
Background: Hyperactivity related behaviors as well as inattention and impulsivity are regarded as t...
The selective norepinephrine (NE) transporter inhibitor atomoxetine (formerly called tomoxetine or L...
Methylphenidate and atomoxetine are effective in treating attention-deficit/hyperactivity disorder (...
Background. Methylphenidate and atomoxetine are commonly prescribed for treating attention deficit h...
4. Pharmacol Res. 2010 Dec;62(6):523-9. Epub 2010 Aug 5. Sub-chronic exposure to atomoxetine up-r...
Objective: The effects of a promising pharmacological treatment for attention-deficit/hyperactivity ...
Background: Atomoxetine, a selective noradrenaline reuptake inhibitor (SNRI) licensed for the treatm...
Copyright © 2013 Ramiz M. Salimov, Georgy I. Kovalev. This is an open access article distributed und...
RATIONALE: Attention-deficit hyperactivity disorder (ADHD) is the most frequently diagnosed neur...
The stimulant methylphenidate and the non-stimulant atomoxetine are widely used for the treatment of...
Objective: The effects of a promising pharmacological treatment for attention-deficit/hyperactivity ...
Attention-deficit/hyperactivity disorder (ADHD) is a complex neurobehavioral disorder that is charac...